INSULIN OPTIMIZATION SYSTEMS AND TESTING METHODS WITH ADJUSTED EXIT CRITERION ACCOUNTING FOR SYSTEM NOISE ASSOCIATED WITH BIOMARKERS

Invention Grant

EP3614394B1 INSULIN OPTIMIZATION SYSTEMS AND TESTING METHODS WITH ADJUSTED EXIT CRITERION ACCOUNTING FOR SYSTEM NOISE ASSOCIATED WITH BIOMARKERS 有权

Patent Title: INSULIN OPTIMIZATION SYSTEMS AND TESTING METHODS WITH ADJUSTED EXIT CRITERION ACCOUNTING FOR SYSTEM NOISE ASSOCIATED WITH BIOMARKERS
Application No.: EP19192445.5

Application Date: 2011-06-14
Publication No.: EP3614394B1

Publication Date: 2024-02-21
Inventor: BOUSAMRA, Steven , DUKE, David L. , PERCIVAL, Matt , SONI, Abhishek S.
Assignee: Roche Diabetes Care GmbH,F. Hoffmann-La Roche AG
Current Assignee: Roche Diabetes Care GmbH,F. Hoffmann-La Roche AG
Current Assignee Address: Sandhofer Straße 116 68305 Mannheim DE; Grenzacherstrasse 124 4070 Basel CH
Agency: Meinel, Anne Julia
Priority: US81879510 20100618
Main IPC: G16Z99/00
IPC: G16Z99/00 ; A61B5/145 ; G16H50/20

Public/Granted literature

Information query

Global Dossier Espacenet

IPC分类:

G	物理
G16	特别适用于特定应用领域的信息通信技术
G16Z	未列入其他类目的特别适用于特定应用领域的信息和通信技术
G16Z99/00	本小类的其他各组中不包含的技术主题